<unk>  chemotherapy is generally reserved for use in the treatment of serious and aggressive forms of hematological malignancy. There are serious side effects and complications arising from the administration of the various agents, which require careful management in an appropriate health-care setting. Patients who receive<unk>  receive a careful work-up to assess their overall wellness prior to the commencement of the regimen, in order to minimise undesirable outcomes. Patients considered for the protocol will generally be under 65.
Hyper-CVAD
RASopathy
Combined hyperlipidemia
types of Dyslipidemia
Macdonald triad
Shwartzman phenomenon
Jod-Basedow phenomenon
Angiolathyrism